Preliminary in vitro studies on two potent, water-soluble trimethoprim analogues with exceptional species selectivity against dihydrofolate reductase from Pneumocystis carinii and Mycobacterium avium
- 1 April 2004
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (7) , 1811-1815
- https://doi.org/10.1016/j.bmcl.2003.12.103
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole1Transplantation, 2003
- New Insights Into Transmission, Diagnosis, and Drug Treatment of Pneumocystis carinii PneumoniaJAMA, 2001
- Treatment of Infection Due to Pneumocystis cariniiAntimicrobial Agents and Chemotherapy, 1998
- Mobilizatiod/Transplantation of Peripheral Blood Progenitor Cells for Aggressive Non-Hodgkin's Lymphoma with Marrow InvolvementLeukemia & Lymphoma, 1997
- EFFECTIVENESS OF DAILY LOW-DOSE CONTRIMOXAZOLE PROPHYLAXIS FORPNEUMOCYSTIS CARINII PNEUMONIA IN LIVER TRANSPLANTATION-AN OPEN CLINICAL TRIALTransplantation, 1996
- Prophylactic antibiotics for the prevention of early infection in multiple myelomaThe American Journal of Medicine, 1996
- Pneumocystis carinii Pneumonia in Patients With Primary Brain TumorsArchives of Neurology, 1991
- Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other ImmunodeficienciesAnnals of Internal Medicine, 1984
- TRIMETHOPRIM, A SULPHONAMIDE POTENTIATORBritish Journal of Pharmacology, 1968
- 5-Benzyl-2,4-diaminopyrimidines as Antibacterial Agents. I. Synthesis and Antibacterial Activity in vitroJournal of Medicinal Chemistry, 1962